South Carolina Healthcare
Compliance Guide

South Carolina presents a moderately regulated environment for healthcare companies, balancing patient access with traditional oversight. The state has embraced telehealth expansion, particularly following the COVID-19 pandemic, making it a viable option for delivering care. However, it maintains a strong Corporate Practice of Medicine (CPOM) doctrine, which significantly impacts business structuring and ownership. Key regulatory bodies include the South Carolina Board of Medical Examiners, the South Carolina Board of Nursing, and the South Carolina Board of Pharmacy. Recent legislative actions have primarily focused on solidifying telehealth flexibilities and addressing specific provider scopes of practice. The business climate is generally favorable, but strict adherence to CPOM and professional licensure requirements is paramount. Companies looking to operate in South Carolina must understand the nuances of its professional licensure laws, which often dictate the permissible relationships between licensed professionals and corporate entities. The state has shown a willingness to adapt its regulatory framework to technological advancements, but this adaptation is often incremental and requires careful monitoring. For instance, while telehealth is broadly permitted, specific prescribing rules, especially for controlled substances, remain stringent. Companies must also be aware of the state's fee-splitting prohibitions and professional corporation requirements, which are critical for maintaining compliance and avoiding enforcement actions. The overall trend suggests continued support for expanding healthcare access, but always within the confines of established professional practice standards and consumer protection. Navigating this landscape requires a deep understanding of both the statutory framework and the interpretive guidance from various professional boards.

South Carolina maintains a strong Corporate Practice of Medicine (CPOM) doctrine, making it a restrictive state for non-physician ownership of medical practices. The legal basis for SC's CPOM is primarily derived from common law principles and reinforced by various statutes that define the practice of medicine and prohibit the unauthorized practice of a profession. While there isn't a single overarching CPOM statute, the cumulative effect of professional licensing acts (e.g., S.C. Code Ann. § 40-47-20 for physicians) and prohibitions against fee-splitting (e.g., S.C. Code Ann. § 40-47-110(C)(13)) effectively enforces the doctrine. The South Carolina Board of Medical Examiners consistently interprets these provisions to mean that only licensed physicians or professional entities owned by licensed physicians can employ other physicians or control the delivery of medical services. This means that non-physicians, including corporations, generally cannot own or operate entities that directly engage in the practice of medicine. This restriction extends to various healthcare settings, including medspas, dental practices, and wellness clinics offering medical services. For example, a medspa offering injectables or laser treatments, which constitute the practice of medicine, must be owned by a physician or a professional entity owned by physicians. Non-physicians can own the 'management' or 'administrative' aspects of a healthcare business, but they cannot exercise control over clinical decision-making, physician employment, or the revenue generated from professional medical services. This distinction necessitates the use of a Professional Corporation (PC) or Professional Limited Liability Company (PLLC) for the medical practice, which is then typically owned by the licensed physician(s). A separate Management Services Organization (MSO) owned by non-physicians can provide administrative, non-clinical services to the PC/PLLC. However, the MSO cannot dictate clinical protocols, employ licensed medical professionals (other than administrative staff), or share in professional fees. This structure is critical for telehealth companies operating in South Carolina, as the originating entity providing medical services must comply with these ownership restrictions. Any arrangement that appears to allow a lay entity to control medical practice or share in professional fees is subject to scrutiny and potential enforcement action by the Board of Medical Examiners, which can result in license revocation or other disciplinary measures for the licensed professionals involved.

South Carolina has adopted a progressive stance on telehealth, allowing for the establishment of a valid provider-patient relationship via telehealth, provided certain conditions are met. The primary statute governing telehealth is S.C. Code Ann. § 40-47-113, which defines 'telemedicine' and outlines requirements. A provider-patient relationship can be established without a prior in-person visit, but the standard of care remains the same as for in-person encounters. This means the provider must obtain a medical history, perform an appropriate examination, and establish a diagnosis before providing treatment. All modalities are generally permitted, including synchronous audio-visual (video conferencing), synchronous audio-only (telephone), and asynchronous (store-and-forward) technologies. However, the choice of modality must be clinically appropriate for the service being rendered. For instance, a comprehensive initial evaluation for a complex condition might require video, while a follow-up for a stable condition could be audio-only. Asynchronous modalities are acceptable for certain services, such as radiology interpretations or pathology reports, but generally not for establishing an initial diagnosis and treatment plan for new patients without supplemental synchronous interaction. There are no specific telehealth registration requirements for providers beyond their standard professional licensure. However, out-of-state providers must be licensed in South Carolina to provide services to SC patients, unless they fall under specific interstate compacts (e.g., IMLC for physicians, NLC for nurses). Informed consent is a critical component of telehealth in South Carolina. Providers must obtain informed consent from the patient, or the patient's legal representative, prior to the delivery of telemedicine services. This consent must include information about the services, the technology used, potential risks, and privacy practices. While not explicitly requiring a separate 'telehealth consent,' it's best practice to ensure the patient understands the nature of receiving care remotely. There are no specific geographic restrictions within South Carolina for telehealth delivery; providers can treat patients anywhere within the state, provided they are licensed in SC. The South Carolina Board of Medical Examiners provides further guidance on the appropriate use of telehealth, emphasizing that it should be used to improve access to care while maintaining patient safety and quality.

South Carolina has specific and stringent rules for prescribing controlled substances via telehealth, particularly after the expiration of federal COVID-19 waivers. For non-controlled substances, prescribing via telehealth is generally permissible following a valid provider-patient relationship and adherence to the standard of care. However, for controlled substances, the landscape is more complex. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before a controlled substance can be prescribed via the internet. While federal waivers during the COVID-19 public health emergency allowed for telehealth prescribing of controlled substances without a prior in-person visit, these waivers have largely expired or are in transition. As of the anticipated 2025-2026 timeframe, it is expected that a prior in-person examination will likely be required for prescribing Schedule II-V controlled substances via telehealth, unless new federal regulations or state-specific exceptions are enacted. The DEA has proposed new rules that may allow for some initial telehealth prescribing of controlled substances without an in-person visit, but with strict limitations (e.g., a 30-day supply limit for Schedule III-V, and no Schedule II without an in-person visit). Providers must check the most current federal DEA guidance and South Carolina's specific regulations. South Carolina's Prescription Drug Monitoring Program (PDMP), known as SCRxS, is mandatory. S.C. Code Ann. § 44-53-1630 requires prescribers to check the PDMP before prescribing a Schedule II, III, IV, or V controlled substance, and at least every three months for ongoing therapy. This applies equally to telehealth and in-person encounters. There are specific quantity and refill limitations for controlled substances. For example, S.C. Code Ann. § 44-53-360 specifies limits for Schedule II substances, often requiring a new prescription for each fill. For GLP-1s (e.g., Wegovy, Ozempic), testosterone, and stimulants (e.g., Adderall, Ritalin), these are often controlled substances or have high abuse potential, leading to increased scrutiny. Prescribing these via telehealth without a prior in-person exam is highly risky and likely non-compliant without explicit federal or state exceptions. The South Carolina Board of Medical Examiners and Board of Pharmacy closely monitor prescribing practices, and any deviation from established standards, especially for controlled substances, can lead to severe disciplinary action.

South Carolina has a structured, but not full, practice authority model for Advanced Practice Registered Nurses (APRNs), and PAs operate under physician supervision. For Nurse Practitioners (NPs), South Carolina does not grant full practice authority. NPs must practice under a 'supervision agreement' or 'collaborative practice agreement' with a physician, as outlined in S.C. Code Ann. § 40-33-34. This agreement must define the scope of practice, the methods of supervision, and the types of medical acts the NP is authorized to perform. While the agreement provides a framework, NPs have significant autonomy within their defined scope, including the ability to diagnose, treat, and prescribe. However, the physician remains ultimately responsible for the overall care provided. The physician must be available for consultation and review a certain percentage of the NP's charts, as specified by the Board of Nursing and Board of Medical Examiners regulations. Physician Assistants (PAs) in South Carolina also operate under a 'supervision agreement' with a licensed physician, as per S.C. Code Ann. § 40-47-195. PAs cannot practice independently; their scope is defined by their supervising physician's scope of practice and the terms of their agreement. The agreement must be approved by the Board of Medical Examiners. PAs can perform medical services that are within their education, training, and experience, and are delegated by their supervising physician. This includes diagnosing, treating, and prescribing medications (including controlled substances, with specific limitations). For Medical Assistants (MAs) in medspas or other clinical settings, their scope of practice is strictly limited to delegated tasks that do not require independent medical judgment. MAs cannot perform invasive procedures, administer injectables, or conduct initial patient assessments. These tasks must be performed by a licensed physician, NP, or PA, or delegated to a licensed nurse (RN, LPN) under appropriate supervision. Delegation rules are crucial: tasks must be within the delegating professional's scope of practice, and the MA must be adequately trained and supervised. Any direct patient care that constitutes the practice of medicine or nursing, such as administering Botox or fillers, cannot be delegated to an MA. Supervision requirements are robust across all mid-level providers, emphasizing patient safety and physician oversight.

Navigating business structuring in South Carolina requires careful consideration of its strong Corporate Practice of Medicine (CPOM) doctrine and fee-splitting prohibitions. The most common compliant structure for healthcare businesses in SC is the Professional Corporation (PC) or Professional Limited Liability Company (PLLC) model, often paired with a Management Services Organization (MSO). A PC/PLLC, owned exclusively by licensed healthcare professionals (e.g., physicians for a medical practice, dentists for a dental practice), directly employs the licensed providers and delivers clinical services. This entity holds the necessary licenses and permits for the practice of the profession. The MSO, which can be owned by non-physicians or investors, provides all non-clinical, administrative, and management services to the PC/PLLC. These services typically include billing, scheduling, marketing, IT, human resources for administrative staff, and facility management. The MSO charges the PC/PLLC a fair market value (FMV) fee for these services, which must be clearly defined in a Management Services Agreement (MSA). Fee-splitting is strictly prohibited in South Carolina under S.C. Code Ann. § 40-47-110(C)(13) and other professional practice acts. This means an MSO cannot share in the professional fees generated by the PC/PLLC based on a percentage of revenue or profit. The MSO's fee must be a fixed fee, a cost-plus model, or another FMV-based arrangement that does not fluctuate directly with the volume or value of professional services rendered. This separation ensures that clinical decisions are not influenced by financial incentives from non-licensed entities. Professional corporations (PCs) are governed by S.C. Code Ann. Title 33, Chapter 19 (Professional Corporations Act). These entities are specifically designed for licensed professionals to practice their profession. Ownership of a PC is restricted to individuals licensed to practice the profession for which the corporation is organized. For telehealth companies, this means the entity providing the medical services to SC patients must be a SC-licensed PC/PLLC owned by SC-licensed physicians. Structuring ownership for compliance involves ensuring that all clinical decision-making, employment of licensed professionals, and direct patient care revenue flow through the physician-owned PC/PLLC, while the MSO provides only legitimate, arms-length administrative support at FMV. Any attempt to circumvent CPOM or fee-splitting rules through overly complex or financially interdependent structures will be scrutinized by regulatory boards.

South Carolina has seen ongoing legislative and regulatory activity impacting healthcare, particularly in telehealth and scope of practice. In the 2024 legislative session, there was continued focus on making permanent some of the telehealth flexibilities that emerged during the COVID-19 Public Health Emergency. While specific bill numbers vary, the general trend is towards solidifying the ability to establish a patient-provider relationship via telehealth without a prior in-person visit, and ensuring payment parity for telehealth services. However, the stricter rules for controlled substance prescribing via telehealth, especially for Schedule II substances, are expected to remain, aligning with federal DEA guidance. There have been discussions around further expanding the scope of practice for certain mid-level providers, though full practice authority for NPs remains a contentious issue. Any changes would likely involve amendments to S.C. Code Ann. § 40-33-34. The South Carolina Board of Medical Examiners continues to issue guidance and enforce existing regulations, with recent enforcement actions often targeting inappropriate prescribing practices, particularly for controlled substances, and violations of CPOM through improper business arrangements. The state has not yet joined the Interstate Medical Licensure Compact (IMLC) for physicians, meaning physicians must obtain full SC licensure to practice in the state. However, South Carolina is a member of the Nurse Licensure Compact (NLC), allowing nurses with a compact license from another compact state to practice in SC. There is ongoing advocacy for SC to join the IMLC, which would streamline physician licensure for multi-state telehealth operations. Companies should monitor the South Carolina General Assembly's legislative session for any new bills related to telehealth, professional licensure, or healthcare business operations, as well as announcements from the Board of Medical Examiners and Board of Pharmacy. The regulatory environment is dynamic, and staying abreast of these changes is crucial for maintaining compliance.

For healthcare companies entering South Carolina, a structured approach to compliance is essential. Here's a practical guide: 1. Establish a Compliant Business Structure: Given SC's strong CPOM, plan for a Professional Corporation (PC) or Professional Limited Liability Company (PLLC) owned by SC-licensed physicians for clinical services, coupled with a separate Management Services Organization (MSO) for administrative support. Ensure the Management Services Agreement (MSA) reflects fair market value (FMV) for services and avoids fee-splitting. 2. Physician Licensure: Ensure all physicians providing services to SC patients are fully licensed by the South Carolina Board of Medical Examiners. This is a non-negotiable first step. Out-of-state compact licenses (e.g., IMLC) are not recognized for physicians in SC. 3. Telehealth Protocol Development: Implement clear telehealth protocols that adhere to S.C. Code Ann. § 40-47-113. This includes procedures for establishing a valid provider-patient relationship, obtaining informed consent, documenting telehealth encounters, and ensuring the standard of care is met. 4. Controlled Substance Prescribing Review: Develop stringent policies for controlled substance prescribing via telehealth. Assume an in-person visit is required for initial prescriptions of controlled substances unless federal DEA guidance explicitly allows otherwise for specific schedules and quantities. Mandate PDMP (SCRxS) checks for all controlled substance prescriptions. 5. Scope of Practice Adherence: For NPs and PAs, ensure valid and up-to-date supervision or collaborative practice agreements are in place and approved by the relevant boards. Clearly define the scope of practice for all mid-level providers and ensure strict adherence to delegation rules for support staff (e.g., MAs). 6. Fee-Splitting Avoidance: Review all financial arrangements, especially those between the MSO and PC/PLLC, to ensure strict compliance with anti-fee-splitting laws. Avoid percentage-based compensation for the MSO. 7. HIPAA and State Privacy Compliance: Implement robust data privacy and security measures compliant with HIPAA and any specific SC state privacy laws. 8. Ongoing Monitoring: Regularly monitor legislative updates from the South Carolina General Assembly and regulatory guidance from the Board of Medical Examiners, Board of Nursing, and Board of Pharmacy. Common pitfalls include underestimating CPOM enforcement, failing to obtain proper physician licensure, improper controlled substance prescribing via telehealth, and non-compliant financial arrangements between MSOs and professional entities. Licensing and setup can take several months, so plan accordingly.